Clinical and Immunological Predictors of Hemorrhagic Fever with Renal Syndrome Outcome during the Early Phase
Open Access
Abstract
The ability to accurately predict the early progression of hemorrhagic fever with renal syndrome (HFRS) is crucial for reducing morbidity and mortality rates in severely affected patients. However, the utility of biomarkers for predicting clinical outcomes remains elusive in HFRS. The aims of the current study were to analyze the serum levels of immune function-related proteins and identify novel biomarkers that may help ascertain clinical outcomes of HFRS. Enzyme-linked immunosorbent assay, Luminex, and bioanalyzer assays were used to quantitatively detect 15 biomarkers in 49 serum samples of 26 patients with HFRS. High hemoglobin (HGB) and low urine output (UO) levels were identified as potential biomarkers associated with the acute HFRS. The serum soluble urokinase plasminogen activator receptor (suPAR) and C-X-C motif chemokine ligand 10 (CXCL10) values increased in the early phase of diseases. Elevated suPAR, interleukin-10 (IL-10), CXCL10, and decreased transforming growth factor-beta 3 (TGF-β3) were representative predictors of the disease severity. Upregulation of the HGB showed a significant correlation with high levels of suPAR and CXCL10. Reduced UO positively correlated with increased suPAR, CXCL10, and TGF-β2, and decreased vascular endothelial growth factor and TGF-β3. The changing HGB and UO criteria, high suPAR, IL-10, CXCL10, and low TGF-β3 of HFRS raise significant awareness for physicians regarding prospective biomarkers for monitoring early warning signs of HFRS. This study provides critical insights into the clinical and immunological biomarkers for disease severity and progression in patients with HFRS to identify early predictions of fatal outcomes.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017M3A9E4061992)
- Agency for Defense Development (UE202026GD)
This publication has 61 references indexed in Scilit:
- Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus InfectionPLOS ONE, 2013
- Endothelial Cells Elicit Immune-Enhancing Responses to Dengue Virus InfectionJournal of Virology, 2012
- suPAR as a prognostic biomarker in sepsisBMC Medicine, 2012
- Cytokine expression during early and late phase of acute Puumala hantavirus infectionBMC Immunology, 2011
- Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndromeBMC Infectious Diseases, 2011
- Hantavirus Infection: A Neglected Diagnosis in Thrombocytopenia and Fever?Mayo Clinic Proceedings, 2010
- A Global Perspective on Hantavirus Ecology, Epidemiology, and DiseaseClinical Microbiology Reviews, 2010
- Decision Tree Algorithms Predict the Diagnosis and Outcome of Dengue Fever in the Early Phase of IllnessPLOS Neglected Tropical Diseases, 2008
- Imported Fatal Hantavirus Pulmonary SyndromeEmerging Infectious Diseases, 2007
- Free HemoglobinAnnals of the New York Academy of Sciences, 2007